Manufacturing facility undergoing validation remediation assessment
Home / Validation Remediation
Service · Validation Remediation

Remediation that closes findings — for good.

An FDA 483, a warning letter, or a failed customer audit puts your operation on a clock. Responses written under pressure promise fixes; follow-up inspections check whether the evidence exists. We triage every observation to its root cause, sequence corrective actions by risk, and build the validation evidence your response commits to — so the next inspection finds closures, not repeats.

WHY NOW

Enforcement doesn't wait for you to be ready.

Observations carry response deadlines. Warning letters escalate. And every commitment you make in writing becomes the checklist for the follow-up inspection.

15 business daysThe standard window to respond to an FDA 483 in writing — with commitments specific enough to satisfy the agency.
Root causeMost remediation fails here: symptoms get fixed, causes don't. We trace each observation to the system failure behind it before a single CAPA is written.
Re-inspectionThe follow-up visit checks one thing: did you do what you promised? We sequence the work so closures are real and evidence-backed.
WHERE IT BREAKS

The four ways remediation goes wrong.

We've seen these patterns from the other side of the table.

01

Promises Without Evidence

Responses commit to new SOPs and retraining while the underlying validation gaps stay untouched. The inspector returns, asks for the qualification records, and the finding repeats.

02

CAPAs That Treat Symptoms

Deviations close with ‘retrained operator’ while the unvalidated process keeps producing the same deviation. Repeat observations escalate faster than first ones.

03

Everything at Once, Nothing Finished

Twenty open actions, no sequencing. High-risk gaps wait behind low-risk paperwork while the re-inspection date approaches.

04

No One Owns the Evidence

Actions are ‘done’ but the records are scattered, unsigned, or missing. A closure without evidence is a finding waiting for its second inspection.

OUR METHOD

A controlled path from findings to closure.

Four phases, sequenced by risk and deadline — built around what the follow-up inspection will actually check.

Observation Triage

Every 483 observation, warning-letter item, or audit finding is mapped to its root cause and risk-ranked. You get a register that separates ‘fix this week’ from ‘fix this quarter’ — and says why.

Remediation Planning

Each root cause gets a corrective-action plan with owner, evidence deliverable, and deadline. The plan becomes the backbone of your written response to the agency.

Evidence Building

We execute the missing validation: qualification protocols, system validation, data-integrity controls, documentation — the records your response promised.

Re-Readiness Verification

Before the follow-up inspection, we verify every committed action the way an inspector would: evidence first, assertions never. Gaps found here are cheap; gaps found by FDA are not.

WHERE IT APPLIES

One method, five industries.

Cannabis is our home base — the method was built there first. The same evidence discipline serves each industry below, mapped to its own regulations.

Food & Beverage

Preventive controls, supplier verification, environmental monitoring, and traceability under 21 CFR Part 117 and FSMA.

Explore the food & beverage program →

Dietary Supplements

Component qualification, master manufacturing records, and laboratory controls under 21 CFR Part 111.

Explore the supplements program →

Cosmetics

Safety substantiation, GMP records, and adverse-event readiness under MoCRA.

Explore the cosmetics program →

Pet Food

Preventive controls for animal food, supplier programs, and sanitation under 21 CFR Part 507.

Explore the pet food program →

QUESTIONS

Remediation, answered.

We just received a 483. How fast can you start?

Immediately. Triage begins with your 483 and existing records — no waiting for a formal kickoff. The 15-business-day response window drives the schedule, and we build the plan to meet it.

Can you write our FDA response letter?

We build the technical backbone: root-cause analysis, corrective-action commitments, and the evidence timeline. Your quality leadership signs the letter — we make sure every sentence in it is defensible.

What if the warning letter is about data integrity?

Then the remediation is a data-integrity program: audit-trail controls, access remediation, retrospective review where warranted, and ALCOA+ practices that change behavior. Our data-integrity practice covers the full method.

Do you work alongside our existing QA team?

Yes — that's the normal model. Your team owns the quality system; we bring remediation bandwidth and outside-in discipline. We leave your people stronger than we found them, with templates and routines that persist.

How do we keep this from happening again?

Every remediation ends with preventive controls: periodic review schedules, change-control discipline, and monitoring routines tied to the root causes we found. Closure without prevention is just a pause.

Don't let the first gap be found under pressure.

Start with a confidential conversation about your observations — what's cited, what's due, and what the path to closure looks like.